Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2022 | 643 | 1.610 |
Why?
|
| Cholestenones | 2 | 2019 | 2 | 1.080 |
Why?
|
| alpha-Synuclein | 3 | 2022 | 28 | 1.070 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2020 | 93 | 0.990 |
Why?
|
| Mitochondrial Membranes | 3 | 2020 | 45 | 0.930 |
Why?
|
| Microtubules | 6 | 2018 | 104 | 0.930 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2014 | 114 | 0.880 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2019 | 10 | 0.710 |
Why?
|
| Protective Agents | 1 | 2019 | 36 | 0.690 |
Why?
|
| Cell Cycle | 1 | 2020 | 312 | 0.680 |
Why?
|
| Voltage-Dependent Anion Channels | 4 | 2022 | 40 | 0.540 |
Why?
|
| Neoplasms | 2 | 2020 | 1664 | 0.510 |
Why?
|
| Vinblastine | 2 | 2013 | 40 | 0.480 |
Why?
|
| Tyrosine | 1 | 2013 | 196 | 0.420 |
Why?
|
| Tubulin Modulators | 2 | 2014 | 10 | 0.410 |
Why?
|
| Cell Movement | 2 | 2014 | 630 | 0.390 |
Why?
|
| Lipid Bilayers | 3 | 2019 | 24 | 0.380 |
Why?
|
| Glioblastoma | 1 | 2013 | 219 | 0.360 |
Why?
|
| Endothelial Cells | 1 | 2013 | 384 | 0.360 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 1851 | 0.340 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 467 | 0.300 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1034 | 0.300 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 499 | 0.280 |
Why?
|
| Hep G2 Cells | 3 | 2020 | 68 | 0.270 |
Why?
|
| Neurons | 1 | 2010 | 881 | 0.240 |
Why?
|
| Wallerian Degeneration | 1 | 2022 | 6 | 0.210 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2022 | 8 | 0.210 |
Why?
|
| Protein Binding | 3 | 2019 | 1027 | 0.210 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.200 |
Why?
|
| NAD | 1 | 2022 | 73 | 0.190 |
Why?
|
| Oxygen Consumption | 1 | 2022 | 258 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2019 | 163 | 0.180 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 7 | 0.170 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 9 | 0.170 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 140 | 0.170 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 1172 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2022 | 272 | 0.170 |
Why?
|
| Simvastatin | 1 | 2019 | 34 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 57 | 0.170 |
Why?
|
| RNA Interference | 1 | 2019 | 266 | 0.160 |
Why?
|
| Lovastatin | 1 | 2019 | 78 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 334 | 0.160 |
Why?
|
| Tubulin | 1 | 2018 | 60 | 0.160 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 148 | 0.150 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 434 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 86 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2019 | 524 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 212 | 0.140 |
Why?
|
| Humans | 12 | 2022 | 68549 | 0.140 |
Why?
|
| Cell Survival | 1 | 2019 | 901 | 0.140 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 45 | 0.110 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 100 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 174 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 219 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 300 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 411 | 0.090 |
Why?
|
| Vinca Alkaloids | 1 | 2010 | 3 | 0.090 |
Why?
|
| Comet Assay | 1 | 2010 | 11 | 0.090 |
Why?
|
| PC12 Cells | 1 | 2010 | 36 | 0.090 |
Why?
|
| Animals | 5 | 2022 | 20880 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2013 | 617 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 317 | 0.070 |
Why?
|
| Cell Death | 2 | 2019 | 329 | 0.070 |
Why?
|
| Schwann Cells | 1 | 2022 | 33 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2022 | 22 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 47 | 0.050 |
Why?
|
| Cell Respiration | 1 | 2022 | 47 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 237 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 5300 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 298 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2022 | 222 | 0.040 |
Why?
|
| Anthracenes | 1 | 2019 | 26 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 8 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1070 | 0.040 |
Why?
|
| Nanopores | 1 | 2019 | 4 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 51 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2019 | 31 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 29 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1174 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7028 | 0.040 |
Why?
|
| Macrophages | 1 | 2022 | 647 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 74 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 791 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 447 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 246 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2018 | 362 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 314 | 0.040 |
Why?
|
| Kinetics | 1 | 2018 | 1047 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 946 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 981 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2014 | 57 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 95 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 64 | 0.030 |
Why?
|
| Mice | 2 | 2019 | 8474 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 132 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2673 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Algorithms | 1 | 2019 | 1195 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 80 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 94 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 782 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2013 | 140 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 294 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 331 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 954 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 304 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 532 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 442 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 682 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5710 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 2689 | 0.020 |
Why?
|
| Female | 2 | 2019 | 38021 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14842 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1533 | 0.010 |
Why?
|